![Stacy Coen](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Stacy Coen
Corporate Officer/Principal chez
IMMUNOGEN, INC.
Fortune : 435 $ au 31/05/2026
Profil
Stacy A. Coen is Chief Business Officer & Senior Vice President at ImmunoGen, Inc. since 2020.
Current roles also include Member at Massachusetts Biotechnology Council, Trustee at Huntington's Disease Society of America, and Member at Alliance for Regenerative Medicine.
Former positions include Independent Director at FibroBiologics, Inc. from 2021 to 2026, Vice President at Genzyme Corp., and Vice President-Business Development at Editas Medicine, Inc. Education includes undergraduate studies at the University of Massachusetts and an MBA from the University of Virginia Darden School of Business.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
FIBROBIOLOGICS, INC. 0,01 % | 24/04/2026 | 375 ( 0,01 % ) | 435 $ | 31/05/2026 |
Postes actifs de Stacy Coen
| Sociétés | Poste | Début |
|---|---|---|
| IMMUNOGEN, INC. | Corporate Officer/Principal | 03/06/2020 |
Alliance for Regenerative Medicine
 Alliance for Regenerative Medicine Medical/Nursing ServicesHealth Services Promotes legislative, regulatory and reimbursement initiatives for regenerative medicine | Corporate Officer/Principal | - |
Massachusetts Biotechnology Council
 Massachusetts Biotechnology Council Miscellaneous Commercial ServicesCommercial Services Operates as an association of biotechnology companies | Corporate Officer/Principal | - |
Huntington's Disease Society of America
 Huntington's Disease Society of America Miscellaneous Commercial ServicesCommercial Services The Huntington's Disease Society of America is a nonprofit organization dedicated to supporting individuals and families affected by Huntington’s disease, a fatal genetic disorder causing progressive nerve cell breakdown in the brain. The non-profit company is based in New York, NY. The organization provides resources including education on symptoms, stages, genetics, and care management; support groups; social workers; telehealth services; and a network of centers offering clinical care. It funds research to advance scientific understanding and develop treatments, supports researchers through grants and fellowships, facilitates patient participation in clinical trials, and offers continuing education for healthcare professionals. The society emphasizes community engagement through donations, volunteering, advocacy, and events, including youth-focused programs. It also provides caregiver resources, professional training, and promotes physical therapy guidelines. | Directeur/Membre du Conseil | - |
Anciens postes connus de Stacy Coen
| Sociétés | Poste | Fin |
|---|---|---|
| FIBROBIOLOGICS, INC. | Directeur/Membre du Conseil | 22/06/2026 |
Genzyme Corp.
 Genzyme Corp. Pharmaceuticals: MajorHealth Technology Develops and manufactures therapies for rare diseases, multiple sclerosis, immunology & oncology | Corporate Officer/Principal | - |
| EDITAS MEDICINE, INC. | Corporate Officer/Principal | - |
Formation de Stacy Coen
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
54
Relations au 1er degré
9
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 9 |
|---|---|
ImmunoGen, Inc.
 ImmunoGen, Inc. BiotechnologyHealth Technology Develops anticancer therapeutics | Health Technology |
Genzyme Corp.
Genzyme Corp. Pharmaceuticals: MajorHealth Technology Develops and manufactures therapies for rare diseases, multiple sclerosis, immunology & oncology | Health Technology |
University of Massachusetts
 University of Massachusetts Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Massachusetts Biotechnology Council
Massachusetts Biotechnology Council Miscellaneous Commercial ServicesCommercial Services Operates as an association of biotechnology companies | Commercial Services |
Huntington's Disease Society of America
Huntington's Disease Society of America Miscellaneous Commercial ServicesCommercial Services The Huntington's Disease Society of America is a nonprofit organization dedicated to supporting individuals and families affected by Huntington’s disease, a fatal genetic disorder causing progressive nerve cell breakdown in the brain. The non-profit company is based in New York, NY. The organization provides resources including education on symptoms, stages, genetics, and care management; support groups; social workers; telehealth services; and a network of centers offering clinical care. It funds research to advance scientific understanding and develop treatments, supports researchers through grants and fellowships, facilitates patient participation in clinical trials, and offers continuing education for healthcare professionals. The society emphasizes community engagement through donations, volunteering, advocacy, and events, including youth-focused programs. It also provides caregiver resources, professional training, and promotes physical therapy guidelines. | Commercial Services |
Alliance for Regenerative Medicine
Alliance for Regenerative Medicine Medical/Nursing ServicesHealth Services Promotes legislative, regulatory and reimbursement initiatives for regenerative medicine | Health Services |
Editas Medicine, Inc.
 Editas Medicine, Inc. BiotechnologyHealth Technology Manufactures gene editing medicines | Health Technology |
University of Virginia Darden School of Business
 University of Virginia Darden School of Business Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
FibroBiologics, Inc.
 FibroBiologics, Inc. BiotechnologyHealth Technology Develops and commercializes fibroblast-based cell therapies | Health Technology |
Choisissez Zonebourse 
